Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Industry: Biotechnology
OFF LIST - 632 consecutive market days: OFF LIST as of 11/27/2013 Through 11/14/2016
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.